IMF Bentham shares on watch as half-year profit jumps

Shares in Aussie litigation funder IMF Bentham (ASX: IMF) are on watch today after strong statutory numbers in its half-year earnings.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The IMF Bentham Ltd (ASX: IMF) share price is one to watch today after the litigation funder's half-year results release.

a woman

Why are IMF Bentham shares on watch?

IMF Bentham reported a 122% jump in half-year net profit after tax (NPAT) compared to the previous half.

The ASX group posted a $4.9 million NPAT compared to a $25.8 million loss in 2H 2019. This was largely thanks to a 624% jump in legal contract revenue to $142.8 million. IMF Bentham reported a total $152 million in proceeds for the first half of the year. 

There were some big operational highlights during the half including the largest ever individual investment by the group. 

I'd keep an eye on the IMF Bentham share price in early trade as investors mull over today's result.

The group's balance sheet has strengthened throughout the year with cash and receivables totalling $324.8 million compared to $226.1 million as at FY 2019 end. IMF Bentham's net assets also jumped, climbing to $758.4 million versus $515.5 million in the prior half. 

On top of the strong financials, IMF Bentham saw funding applications jump from 516 to 581 in the first half of the year. The group's investments also climbed 46% higher compared to FY 2019 to close at $622.1 million. 

These metric improvements have also been reflected in the IMF Bentham share price, which is up 52.70% in the last 6 months. 

IMF announced an interim dividend of 3.0 cents per share in today's results, compared to no interim payout in previous periods. 

While the headline results are strong, they do include the contributions of IMF's latest acquisition. 

In November 2019, IMF Bentham acquired Omni Bridgeway, a fellow litigation funder, to underpin its growth strategy. 

The purchase cost IMF $50.28 million in consideration to Omni Bridgeway shareholders late last year. 

Foolish takeaway

The headline numbers from IMF Bentham make its shares worth watching today, with investors weighing up those increases versus market expectations. 

Motley Fool contributor Kenneth Hall has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why Kingsgate, Neuren, Newcrest, and Pushpay shares are rising today

These ASX shares are avoiding the market selloff on Tuesday.

Read more »

A young woman wearing overalls and a yellow t-shirt kicks one leg in the air showing excitement over the latest ASX 200 shares to hit 52-week highs
Share Gainers

Why Neuren, Northern Star, Race Oncology, and Westgold shares are storming higher

These ASX shares are starting the week in a positive fashion.

Read more »

A woman wearing yellow smiles and drinks coffee while on laptop.
Share Gainers

Why APM, Macquarie Telecom, Northern Star, and Origin shares are rising today

These ASX shares are having a strong session despite the market selloff.

Read more »

Two boys with cardboard rockets strapped to their backs, indicating two ASX companies with rocketing share prices
Share Gainers

Catch these fast-rising 2 ASX shares before it's too late: Celeste

This pair of stocks rocketed up in February during reporting season, but are still great value for those willing to…

Read more »

three businessmen high five each other outside an office building with graphic images of graphs and metrics superimposed on the shot.
Share Gainers

Why Arafura, Myer, Volpara, and Xero shares are zooming higher

These ASX shares are making their shareholders smile on Thursday.

Read more »

medical asx share price represented by doctor giving thumbs up
Healthcare Shares

Guess which ASX biotech stock just rocketed 29% on big FDA news

The ASX healthcare share is attracting investor interest following FDA approval for its targeted cancer therapy compound.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why Mesoblast, PolyNovo, Pushpay, and Weebit Nano shares are charging higher

These ASX shares are having a strong session despite the market selloff.

Read more »

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why InvoCare, Pentanet, Sayona Mining, and Weebit Nano shares are storming higher

These ASX shares are having a strong session on Tuesday.

Read more »